Pfizer Closes $43B Acquisition Deal with Cancer Drug Maker Seagen
Pfizer has been on an acquisition spree because it seeks to cushion the affect of a projected $17 billion income drop by 2030. Pfizer Inc (NYSE: PFE) has closed a….
Pfizer has been on an acquisition spree because it seeks to cushion the affect of a projected $17 billion income drop by 2030. Pfizer Inc (NYSE: PFE) has closed a….